Thank you.
I just want to know quickly how much money your department puts into approving drugs versus monitoring drug safety after the product is at the market? Are you prepared to restore the federal drug research laboratory that was cut by the Liberals in 1997? And thirdly, with respect to recent studies around gender differences and wait times, can we be assured that the evidence-based benchmarks for medically acceptable wait times address the needs of both women and men?